SineuGene Therapeutics
PrivateLast Round
VC Round
Aug 1, 2024
Company Overview
SineuGene Therapeutics operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a VC Round in August 2024.
SineuGene Therapeutics is a biopharmaceutical company that develops innovative gene therapy treatments for neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SineuGene Therapeutics Comparables
Compare SineuGene Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avrion Therapeutics AG | 88% | |
| AviadoBio | 80% | |
| Eikonoklastes Therapeutics | 79% |
For institutional investors. Book with your work email.
SineuGene Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 1, 2024 | ||||
| Angel | Jan 18, 2023 | ||||
| Seed | Mar 1, 2022 |
For institutional investors. Book with your work email.
SineuGene Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongbo Juli | VC Round |
| MSA Capital | Angel |
| Zhongguancun Capital | VC Round |
| Transfar Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 35% MoM, reaching 2.6K.
- Mar 3, 2026
Monthly visitors increased 44% MoM.
For institutional investors. Book with your work email.
SineuGene Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SineuGene Therapeutics's valuation, stock price, and market status.
Is SineuGene Therapeutics a public or private company?
SineuGene Therapeutics is a private company.
What is the current stock price of SineuGene Therapeutics?
SineuGene Therapeutics is a private company, so its shares have no public market price. Caplight tracks SineuGene Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SineuGene Therapeutics worth (valuation)?
Valuation information for SineuGene Therapeutics is not publicly available.
Can I buy SineuGene Therapeutics stock?
SineuGene Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SineuGene Therapeutics's last funding round?
SineuGene Therapeutics's most recent funding round was VC Round on August 1, 2024.
Who are the main investors in SineuGene Therapeutics?
Key investors in SineuGene Therapeutics include MSA Capital, Zhongguancun Capital.
Will SineuGene Therapeutics IPO soon?
No public IPO plans have been announced for SineuGene Therapeutics.
How can I track SineuGene Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in SineuGene Therapeutics's shares on secondary markets.